Page last updated: 2024-08-23

lodoxamide ethyl and Chronic Disease

lodoxamide ethyl has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez-Gonzalez, JM; Macias-Rodriguez, Y; Rodriguez-Garcia, A1
Bloch-Michel, E; Denis, D; Di Giovanni, A; Helleboid, L; Lecorvec, M; Sebastiani, A; Tazartes, M; Verin, P1

Trials

1 trial(s) available for lodoxamide ethyl and Chronic Disease

ArticleYear
Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    The British journal of ophthalmology, 1998, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Dipeptides; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxamic Acid; Patient Satisfaction; Treatment Outcome

1998

Other Studies

1 other study(ies) available for lodoxamide ethyl and Chronic Disease

ArticleYear
Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
    International ophthalmology, 2018, Volume: 38, Issue:3

    Topics: Administration, Topical; Adult; Aged; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Ophthalmic Solutions; Oxamic Acid; Prospective Studies; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Young Adult

2018